Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome. [electronic resource]
Producer: 20130124Description: 840-9 p. digitalISSN:- 1529-0131
- Adolescent
- Adult
- Age Factors
- Aged
- Antirheumatic Agents -- administration & dosage
- Biomarkers -- metabolism
- Carrier Proteins -- genetics
- Child
- Child, Preschool
- Cryopyrin-Associated Periodic Syndromes -- drug therapy
- Female
- Follow-Up Studies
- Humans
- Interleukin 1 Receptor Antagonist Protein -- administration & dosage
- Male
- Middle Aged
- NLR Family, Pyrin Domain-Containing 3 Protein
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.